Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Amlodipine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Recipient : Brillian Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
Details : Amlodipine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 11, 2023
Lead Product(s) : Amlodipine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Recipient : Brillian Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Nefopam Hydrochloride
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : Unither Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Nefopam HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 22, 2021
Lead Product(s) : Nefopam Hydrochloride
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : Unither Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
